- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03516019
eFHS Messaging Trial
Messaging Intervention Trial in the Electronic Framingham Heart Study (eFHS)
In this research the investigators will develop and test an innovative scalable mobile health and digital cardiovascular monitoring system within a longitudinal deeply characterized cohort with three components: 1) smartphone application (app) designed to promote adherence, integrate digital and mHealth information, and facilitate communication with participants and researchers; 2) smartwatch activity monitoring using the Apple iWatch; and 3) home blood pressure (BP) monitoring using the Withings blood pressure device.
The objective of the messaging trial is to test the effect of messaging strategies on improving participants' long-term use of and engagement with our selected mobile health technologies and on increasing response rate of survey data collection.
Study Overview
Status
Conditions
Detailed Description
The research design includes a cohort eFHS Study and an embedded randomized factorial trial on a subset of the cohort.
For the primary e-cohort, the investigators will build a custom mobile app for use within the Framingham Heart Study (FHS) to digitally collect data, compare it against research clinic-collected data, quantify risk factor burden, and perform CVD risk prediction. The app development will focus on 1) CVD risk factor data that would benefit from more frequent ascertainment than the every four to eight year FHS examination cycles; 2) circumstances where in vivo assessment may be superior to clinic-based assessment; 3) key endpoints of the FHS that are considered FHS landmarks. In addition to the eFHS App, participants will be offered wireless devices (Withings BP) to measure blood pressure and an Apple Watch to measure heart rate and steps per day.
For the messaging trial, the investigators will conduct a randomized factorial trial phase to test the effect of messaging strategies. Participants will be sent a weekly notification through the eFHS app. Participants will be randomly allocated to one of 8 groups defined according to the following: using personalized reminder messaging vs. standard neutral messaging; notification sent on a weekday vs. weekend; notification sent in the morning vs. the evening. The three main comparisons will be simultaneously evaluated according to a 2x2x2 factorial design.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Framingham Heart Study
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria for the eFHS study:
- Participants of the FHS Third Generation, Omni Group 2, and New Offspring Spouse Cohorts attending the in-person examination 3 with access to a smartphone or home internet access and English speaking/reading.
Specifically for the RCT substudy (re: engagement with select mobile health technologies):
- English-speaking individual
- Owns an iPhone with compatible iOS (version 9 or higher);
- Residence in the United States
- Provision of permissions for notifications and data sharing with the Research Center
- Provision of signed and dated informed consent
Exclusion Criteria:
- Participants who do not meet the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Weekday am personalized notices
Participants in this arm receive personalized weekday am notices on Wednesday at 7am.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent at 7 am.
notifications sent on Wednesday
|
|
Experimental: Weekday pm personalized notices
Participants in this arm receive a personalized weekday pm notices on Wednesday at 7pm.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent on Wednesday
notifications sent at 7 pm.
|
|
Experimental: Weekend am personalized notices
Participants in this arm receive a personalized weekend am notices on Saturday at 7am.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent at 7 am.
notifications sent on Saturday
|
|
Experimental: Weekend pm personalized notices
Participants in this arm receive personalized pm notices on Saturday at 7pm.
|
The personalized notices take into account if data were received over the previous week, and accordingly encourages the participant to use the device and send her data, or encourages the participant to continue using the device and sending data.
A library of personalized notices with alternative motivational content was developed.
Each time a notification is sent, it will be drawn at random from the library.
notifications sent at 7 pm.
notifications sent on Saturday
|
|
Experimental: Weekday am standard notices
Participants in this arm receive standard weekday notices on Wednesday at 7am.
|
notifications sent at 7 am.
notifications sent on Wednesday
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
|
Experimental: Weekday pm standard notices
Participants in this arm receive standard weekday notices on Wednesday at 7pm
|
notifications sent on Wednesday
notifications sent at 7 pm.
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
|
Experimental: Weekend am standard notices
Participants in this arm receive standard weekend notices on Saturday at 7am
|
notifications sent at 7 am.
notifications sent on Saturday
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
|
Experimental: Weekend pm standard notices
Participants in this arm receive standard weekend notices on Saturday at 7pm
|
notifications sent at 7 pm.
notifications sent on Saturday
The standard notices which are neutral and invite participants to wear the watch daily and to measure their blood pressure weekly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence at 3 months to the weekly BP recording
Time Frame: 3 months
|
proportion of participants who submit their weekly blood pressure measurement at 3 months
|
3 months
|
|
Adherence at 3 months to the weekly HR recording
Time Frame: 3 months
|
proportion of participants who submit their weekly heart rate measurement at 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence at one month to the weekly BP recording
Time Frame: 1 month
|
proportion of participants who submit their weekly blood pressure measurement at 1 month
|
1 month
|
|
Adherence at one month to the weekly HR recording
Time Frame: 1 month
|
proportion of participants who submit their weekly heart rate measurement at 1 month
|
1 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to survey response
Time Frame: 3 months
|
proportion of participants who complete the eFHS survey at 3 months
|
3 months
|
|
Adherence at 6 months to the weekly BP recording
Time Frame: 6 months
|
Comparison between the groups receiving personalized notices to the groups receiving standard notices
|
6 months
|
|
Adherence at 6 months to the weekly HR recording
Time Frame: 6 months
|
Comparison between the groups receiving personalized notices to the groups receiving standard notices
|
6 months
|
|
Adherence at 6 months to survey response
Time Frame: 6 months
|
Comparison between the groups receiving personalized notices to the groups receiving standard notices
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Joanne Murabito, MD ScM, Framingham Heart Study
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-36586
- 74624 (Other Grant/Funding Number: Robert Wood Johnson Foundation)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
Children's Hospital Medical Center, CincinnatiRecruitingCardiovascular Diseases (CVD)United States
Clinical Trials on personalized notices
-
University of California, Los AngelesNational Institute of Allergy and Infectious Diseases (NIAID)CompletedReminder System for Influenza Vaccines
-
Duke UniversityAgency for Healthcare Research and Quality (AHRQ); Northern Piedmont Carolina... and other collaboratorsCompletedMyocardial Ischemia | Heart Failure | Stroke | Hypertension | Diabetes Mellitus | AsthmaUnited States
-
Duke UniversityNorthern Piedmont Carolina Community Care Partners; North Carolina Division...CompletedCoronary Artery Disease | Hypertension | Diabetes | Asthma | Congestive Heart FailureUnited States
-
University of Colorado, DenverCenters for Disease Control and PreventionCompletedMeningococcal Infection | Varicella | Human Papilloma Virus (HPV) | Tetanus-diphtheria-acellular Pertussis (Tdap)
-
Milton S. Hershey Medical CenterNational Cancer Institute (NCI)CompletedHuman Papillomavirus Vaccines | Adolescent Health ServicesUnited States
-
Hangzhou Normal UniversityCompletedPatients in Minimally Conscious State
-
University of LouisvilleNational Institute of General Medical Sciences (NIGMS)Completed
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingNasal Obstruction | Empty Nose SyndromeUnited States
-
Northwell HealthNational Institute on Aging (NIA)CompletedSleep InsufficiencyUnited States
-
Taipei Medical UniversityCompletedCritical Illness | Mechanical VentilationTaiwan